GNI Group Ltd. (TYO:2160)

GNI Group Revenue

GNI Group had revenue of 6.41B JPY in the quarter ending June 30, 2026, a decrease of -7.51%. This brings the company's total for the last twelve months to 26.53B, up 9.93% year-over-year. In the year 2025, GNI Group had annual revenue of 26.84B with 13.68% growth. That makes GNI Group the 18,715th largest company in the world by revenue and 2,031st in Japan.

• Revenue (ttm): 26.53B
• Revenue Growth: +9.93%
• P/S Ratio: 7.06
• Revenue / Employee: 26.79M
• Employees: 990
• Market Cap: 187.37B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical 19.16B 71.4%
• Medical Device 7.68B 28.6%

By Geography

Chart

• China 18.50B 68.9%
• United States of America 7.53B 28.0%
• Japan 808.00M 3.0%

Fiscal year ended Dec 31, 2025 See the full GNI Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.84B	3.23B	13.68%
Dec 31, 2024	23.61B	-2.40B	-9.22%
Dec 31, 2023	26.01B	8.59B	49.33%
Dec 31, 2022	17.42B	4.73B	37.26%
Dec 31, 2021	12.69B	2.92B	29.85%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error